We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+2.81%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.06%
5 Year Est. Return
+670.57%
10 Year Est. Return
AUM
$2.97B
AUM Growth
-$668M
Cap. Flow
+$51.1M
Cap. Flow %
1.72%
Top 10 Hldgs %
63.58%
Holding
795
New
186
Increased
196
Reduced
157
Closed
179

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$120M
2
LLY icon
Eli Lilly
LLY
+$117M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$70.3M
4
AMZN icon
Amazon
AMZN
+$16.6M
5
PLTR icon
Palantir
PLTR
+$16.1M

Sector Composition

Rank Sector Weight
1 Technology 35.38%
2 Financials 18.17%
3 Healthcare 16.24%
4 Consumer Discretionary 10.31%
5 Communication Services 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKGRW
451
DELISTED
SK Growth Opportunities Corporation Warrant
SKGRW
$16.4K ﹤0.01%
78,013
-157,615
-67% -$45.1K
BUJAW
452
DELISTED
Bukit Jalil Global Acquisition 1 Ltd. Warrants
BUJAW
$16K ﹤0.01%
534,002
+1,550
+0.3% +$55
QOMOR
453
DELISTED
Qomolangma Acquisition Corp. Right
QOMOR
$16K ﹤0.01%
80,100
MSAIW icon
454
MultiSensor AI Holdings Warrant
MSAIW
$949K
$16K ﹤0.01%
632,844
-100
-0% -$3
CYTK icon
455
CALL
Cytokinetics
CYTK
$11B
$16K ﹤0.01%
20,000
ZEOWW
456
Zeo Energy Corp Warrants
ZEOWW
$160K
$16K ﹤0.01%
315,243
+78,194
+33% +$4.1K
ATEK.WS
457
DELISTED
Athena Technology Acquisition Corp. II Redeemable Warrants
ATEK.WS
$15.6K ﹤0.01%
588,263
+491,020
+505% +$14.7K
NVACW
458
DELISTED
NorthView Acquisition Corporation Warrant
NVACW
$15.5K ﹤0.01%
414,176
+100
+0% +$4
PBMWW
459
Psyence Biomedical Warrant
PBMWW
$416K
$15.4K ﹤0.01%
1,220,986
+51,780
+4% +$906
ROCLW
460
DELISTED
Roth CH Acquisition V Co. Warrant
ROCLW
$15.2K ﹤0.01%
322,295
VMCAW
461
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
$15.1K ﹤0.01%
464,595
SBXC.WS
462
DELISTED
SilverBox Corp III Redeemable warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
SBXC.WS
$14.9K ﹤0.01%
148,873
+110,740
+290% +$14.4K
PROCW
463
DELISTED
Procaps Group, S.A. Warrants
PROCW
$14.4K ﹤0.01%
507,251
-8
-0%
CDAQW
464
DELISTED
Compass Digital Acquisition Corp. Warrant
CDAQW
$14.2K ﹤0.01%
233,212
+210,679
+935% +$14.1K
LSBPW
465
DELISTED
LakeShore Biopharma Warrants
LSBPW
$14.1K ﹤0.01%
212,849
-19,150
-8% -$1.21K
QETAR icon
466
Quetta Acquisition Corp Right
QETAR
$14K ﹤0.01%
+10,797
New +$13.7K
WINVW
467
DELISTED
WinVest Acquisition Corp. Warrant
WINVW
$14K ﹤0.01%
1,027,329
BNIXR
468
DELISTED
Bannix Acquisition Corp. Right
BNIXR
$13.9K ﹤0.01%
118,200
-81,362
-41% -$8.93K
DXC icon
469
CALL
DXC Technology
DXC
$1.63B
$13.9K ﹤0.01%
+13,900
New +$277K
DBVT
470
DBV Technologies
DBVT
$807M
$13.8K ﹤0.01%
3,954
ALCE
471
DELISTED
Alternus Clean Energy Inc
ALCE
$13.6K ﹤0.01%
3,200
ZPTA
472
DELISTED
Zapata Computing Holdings Inc. Common Stock
ZPTA
$13.6K ﹤0.01%
50,000
NVNIW
473
Nvni Group Limited Warrants
NVNIW
$578K
$13.3K ﹤0.01%
643,826
-6,600
-1% -$213
AERTW
474
Aeries Technology Warrant
AERTW
$13K ﹤0.01%
371,942
EVTL.WS
475
DELISTED
Vertical Aerospace Ltd. Warrants, each whole warrant exercisable for 1/10th of an ordinary share at an exercise price of $115.00 per share
EVTL.WS
$12.9K ﹤0.01%
698,649
-6,200
-0.9% -$193

Similar funds

Cowen and Company's Q3 2024 Portfolio in Review

As of Q3 2024, Cowen and Company held 795 positions worth $2.97B, down 18% from $3.64B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Cowen and Company's Q3 2024 filing shows 186 new, 196 increased, 157 reduced and 179 closed positions. Its largest new stake was Eli Lilly: 130,399 shares worth $116M. The largest sale was Meta Platforms (Facebook), an estimated $239M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 34% a quarter earlier, followed by Financials and Healthcare.

  • Cowen and Company's largest Q3 2024 buy was Eli Lilly: 130,399 shares worth $116M.
  • Cowen and Company added most to Microsoft in Q3 2024, an estimated $120M increase.
  • Cowen and Company's biggest Q3 2024 reduction was Meta Platforms (Facebook), cutting an estimated $239M.
  • Cowen and Company fully exited Avidity Biosciences in Q3 2024, selling an estimated $210M.
  • Cowen and Company's ten largest holdings make up 64% of its $2.97B portfolio in Q3 2024.
  • Cowen and Company opened 186 new positions and closed 179 in Q3 2024.
  • Cowen and Company's portfolio value fell 18% quarter-over-quarter to $2.97B.

Based on Cowen and Company's 13F filing for Q3 2024, filed 12 Nov 2024.